MedTrace Logo

Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care Pathway

NCT07575880 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-05-13

No results posted yet for this study

Summary

Undiagnosed COPD represents a significant issue in terms of morbidity and mortality, as nearly 50% of smokers with chronic respiratory symptoms also experience impaired quality of life and acute events similar to COPD exacerbations. We aim to study the prevalence of airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population.

Conditions

  • Chronic Obstructive Lung Disease
  • Airflow Obstruction

Interventions

DIAGNOSTIC_TEST

Spirometry

Spirometry to identify airflow obstruction and PRISm (Preserved ration impaired spirometry)

Sponsors & Collaborators

  • Centre Hospitalier de la côte Basque

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-09
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07575880 on ClinicalTrials.gov